Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism
Although peroxisome proliferator receptor (PPAR)-α and PPAR-γ agonist have been developed as chemical tools to uncover biological roles for the PPARs such as lipid and carbohydrate metabolism, PPAR-δ has not been fully investigated. In this study, we examined the effects of the PPAR-δ agonist GW0742...
Main Authors: | Lee, Mi Young, Choi, Ran, Kim, Hong Min, Cho, Eun Ju, Kim, Bo Hwan, Choi, Yeon Sik, Naowaboot, Jarinyaporn, Lee, Eun Young, Yang, Young Chul, Shin, Jang Yel, Shin, Young Goo, Chung, Choon Hee |
---|---|
Format: | Online |
Language: | English |
Published: |
Korean Society for Biochemistry and Molecular Biology
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490079/ |
Similar Items
-
Role of peroxisome proliferator‐activated receptor gamma agonist in improving hepatic steatosis: Possible molecular mechanism
by: Park, Cheol‐Young, et al.
Published: (2012) -
Effects of Peroxisome Proliferator-Activated Receptor-δ Agonist on Cardiac Healing after Myocardial Infarction
by: Park, Jeong Rang, et al.
Published: (2016) -
Protective Effects of Curcumin on Renal Oxidative Stress and Lipid Metabolism in a Rat Model of Type 2 Diabetic Nephropathy
by: Kim, Bo Hwan, et al.
Published: (2016) -
Molecular Characterization and Expression Analysis of the Peroxisome Proliferator Activated Receptor Delta (PPARδ) Gene before and after Exercise in Horse
by: Cho, Hyun-Woo, et al.
Published: (2015) -
Hepatic Subcapsular Steatosis in a Diabetic CAPD Patient Receiving Intraperitoneal Insulin
by: Jang, Eun Chul, et al.
Published: (2006)